Artículos por temáticas

Genetic convergence in brain aging and neurodegeneration: from cellular mechanisms to therapeutic targets

Polu PR, Mishra S.

J Neurogenet. 2025 Oct 16:1-20. doi: 10.1080/01677063.2025.2571127. Online ahead of print.

Effects of exercise modalities on cognitive function and depression in patients with Parkinson's disease: A systematic review and network meta-analysis

Yan HL, Li MM.

Geriatr Nurs. 2025 Oct 22;66(Pt C):103683. doi: 10.1016/j.gerinurse.2025.103683. Online ahead of print.

MTH1 in the disorders of the central nervous system: scope beyond brain tumors and challenges

Padmakumar L, Menon RN, Gopala S, Vilanilam GC.

Acta Neurol Belg. 2025 Oct;125(5):1173-1184. doi: 10.1007/s13760-025-02747-6. Epub 2025 Feb 17.

Clinical and Mechanistic Exploration of Ellagic Acid in Neurodegenerative Diseases: Targeted Neuroprotection Through Cellular and Molecular Mechanisms

Islam MR, Rauf A, Rahaman MS, Al-Imran MIK, Fakir MNH, Akter S, Akter H, Habiba U, Hussain MS, Al Abdulmonem W, Zengin G, Aljohani ASM.

Chem Biodivers. 2025 Oct;22(10):e00105. doi: 10.1002/cbdv.202500105. Epub 2025 May 30.

Standard of care, falling short: Patient views on accessing physical therapy for Parkinson's disease

LeLaurin JH, Salloum RG, Montague M, Ellis TD, Okun MS, Corcos DM.

Parkinsonism Relat Disord. 2025 Oct;139:108002. doi: 10.1016/j.parkreldis.2025.108002. Epub 2025 Aug 19.

Reply to: "Early Indian Age at Onset of Parkinson's: A Case for a Gene-Environment Lens"

Kishore A, Borgohain R, Puthenveedu DK, Rajan R, Pal PK, Kandadai RM, Yadav R, Mehta S, Kumar H, Kumar N, Kukkle PL, Desai S, Shetty K, Wadia PM, Aggarwal A, Agarwal PA, Abbas MM, Krishnan S, Radhakri

Mov Disord. 2025 Oct;40(10):2287-2288. doi: 10.1002/mds.70053. Epub 2025 Sep 30.

The association between anosognosia and neuropsychiatric symptoms in neurodegenerative dementias: a narrative review

Gallingani C, Tondelli M, Vannini P, Zamboni G.

Front Neurol. 2025 Sep 26;16:1649627. doi: 10.3389/fneur.2025.1649627. eCollection 2025.

Reply: "An Insight into Long-Term Outcomes in a Parkinson's Disease Minor Phenomena Cohort"

Schneider RB, Weber MT, Elmer AT, Lizarraga KJ, Richard IH, McDermott MP.

Mov Disord Clin Pract. 2025 Oct;12(10):1688-1689. doi: 10.1002/mdc3.70217. Epub 2025 Jul 14.

Correcting vertical perception to reverse Pisa syndrome in Parkinson's disease: A case report

Jiang H, Wang W, Wei Q, Huang L, Ye S, Gao Q.

Parkinsonism Relat Disord. 2025 Oct;139:108012. doi: 10.1016/j.parkreldis.2025.108012. Epub 2025 Aug 29.

Integrating artificial intelligence with nanodiagnostics for early detection and precision management of neurodegenerative diseases

Hassan YM, Wanas A, Ali AA, El-Sayed WM.

J Nanobiotechnology. 2025 Oct 13;23(1):668. doi: 10.1186/s12951-025-03719-x.

Tremor is Commonly Responsive to Levodopa Along the Natural History of Parkinson's Disease

Mestre TA, Stebbins GT, Luo S, Goetz CG.

Mov Disord Clin Pract. 2025 Oct;12(10):1684-1685. doi: 10.1002/mdc3.70162. Epub 2025 Jun 28.

Akkermansia muciniphila: a microbial guardian against oxidative stress-gut microbiota crosstalk and clinical prospects

Ye WY, Cai Y.

J Transl Med. 2025 Oct 24;23(1):1169. doi: 10.1186/s12967-025-07149-z.

Short-Chain Fatty Acids as a Therapeutic Strategy in Parkinson's Disease: Implications for Neurodegeneration

Ravi A, Umapathy S, Pan I.

Cell Mol Neurobiol. 2025 Oct 22;45(1):90. doi: 10.1007/s10571-025-01609-2.

Providing culturally sensitive sexual medicine for persons with disabilities: a scoping review

Howland R, Tooke B, Deery H, Deery J, Kreschmer J, Arthur M, Wittmann D, Streur C.

Sex Med Rev. 2025 Oct 4;13(4):674-686. doi: 10.1093/sxmrev/qeaf026.

Loxapine for the treatment of psychosis in Lewy body dementia: A case report

Wu L, Jhawar A.

Ment Health Clin. 2025 Oct 1;15(5):252-254. doi: 10.9740/mhc.2025.10.252. eCollection 2025 Oct.